AOMTAge of Mythology the Titans (computer game)
Copyright 1988-2018, All rights reserved.
References in periodicals archive ?
AOMT 2018-3 is backed mainly by nonqualified mortgages (Non-QM) as defined by the Ability to Repay rule (ATR).
The firm has earlier completed a phase two trial that indicated the feasibility of administering the product to paediatric patients with AOMT in an office setting.
Ongoing otorrhoea after VT placement is called, as mentioned above, AOMT. This condition is different from AOM, as Staphylococcus aureus and Pseudomonas aeruginosa play a larger microbiological role in AOMT.
In our initial studies of AOMT, we found almost no anaerobic organisms.
In a prospective, randomized, observer-blind study of 599 children aged 6 months to 12 years (mean age 2.5 years) with AOMT of at least 3 weeks, 297 children received ciprofloxacin/dexamethasone and 302 received ofloxacin (Pediatrics [online] 113 [1], 2004; / cgi / content/full/113/1/e40).
(19.) Roland PS, Dohar JE, Lanier BJ, et al; CIPRODEX AOMT Study Group.
The Food and Drug Administration approved Ciprodex Otic for topical treatment of acute otitis media in children (aged 6 months and older) with tympanostomy tubes (AOMT).
Repeat in the other ear if necessary With AOMT, the tragus should be pumped five times by pushing inward to facilitate penetration of the drops.
New York: Fitch Ratings assigns ratings to Angel Oak Mortgage Trust I, LLC 2018-2 (AOMT 2018-2) as follows:
Angel Oak Capital Advisors, Llc has said that it has completed AOMT 2018-PB1, a USD90m securitization backed by loans originated by the firm's affiliated direct investment property lender - Angel Oak Prime Bridge.
Angel Oak Capital Advisors, LLC (Angel Oak) has announced that it has completed AOMT 2017-3, a USD 210.18 million securitization, primarily backed by non-qualified mortgages (non-QM) fully sourced through the firm's three affiliated mortgage lenders -- Angel Oak Mortgage Solutions, LLC, Angel Oak Home Loans, LLC and Angel Oak Prime Bridge, LLC, the company said.
P aeruginosa, a relatively common cause of acute otitis media with tympanostomy tubes (AOMT) and otitis externa, is increasingly resistant to our mainstays of oral therapy for infections caused by this organism: ciprofloxacin and levofloxacin.